Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japanese Supermarket Giant Plans Dedicated Drug-Sales Areas

This article was originally published in PharmAsia News

Executive Summary

Japan's retail giant, Aeon, says it plans to dedicate areas in its chain of supermarkets exclusively to private-label and cheaper over-the-counter drugs. Supermarkets were cleared to sell OTC drugs without having to have a pharmacist on the premises after the national law was changed recently. Aeon said its own changes are expected to take effect this fall. The set-aside areas are to include OTC drugs with low side effects, and about 60 percent of the stock is to be private-label medicines. Two other supermarket chains have taken similar actions to promote the new availability of lower-cost drugs. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts